Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (13561)	8/18/1998 10:34:00 AM
From: Mkilloran	Respond to of 23519

vlad... I think your beating the 10Q report for the 2nd qtr to death. The ref to plant delays could be just that they had to wait on the FDA approval longer than expected. The 10q is intended to be worst case data not a sales pitch. The plant is approved and in production....relax.

To: VLAD who wrote (13561)	8/18/1998 10:40:00 AM
From: betty moyers	Read Replies (1) \| Respond to of 23519

VLAD, the scripts definately show a bottom over the last 4 to 5 weeks. Interestingly, the data you came up with for 7/17 is significantly higher than the value we were told at the time. Makes you wonder about manipulation of data to scare shareholders. The old number of only 5 above the previous week left us not knowing at the time whether the bottom had been found or whether we were sinking futher into a hole. The correct data fits nicely into a sigh of relief HOUSTON BOTTOM WAS FOUND 5 WEEKS AGO AND WE ARE HOLDING STEADY. I agree with you completely that we aren't likely to see much of an increase until a domestic partner is established. At least we have the feeling that that will be by Sept 30 rather than Dec 31. Three months less to wait.

To: VLAD who wrote (13561)	8/18/1998 10:53:00 AM
From: DaiS	Read Replies (1) \| Respond to of 23519

Vlad, The paragraph in my last post to Edderd is what Dr Christ has told me, I don't know anything else. If we accept the validity of this then Vivus have an ED program, Dr Christ is working with Vivus on this, and they are together pursuing the approach pioneered by Dr Christ and his group. We have the supporting information provided by Vivus at the CC. In my first long post on the subject I said, "The above information is obtained from some published and some in press manuscripts. None acknowledge Vivus as the corporate address of co-authors or as providers of funds to support this research. I do not yet know when Vivus became involved and in what way. My first guess is that they might have come in fairly recently perhaps agreeing to take the work to clinical trials." Message 5319236 Thus I sought confirmation from Dr Christ which I received "Yes, I can indeed confirm that I have a formal relationship with VIVUS. I am a consultant for VIVUS and I am very much involved in their gene therapy program. We are currently in the process of conducting the preclinical studies required for decision making, more than that I cannot tell you. However, based on the published data I share your enthusiasm, and I am, therefore, optimistic about the possibilities." Message 5416846 This latter reassured me considerably. If Vivus supported the work in the current paper, then they asked not to be acknowledged. This is unusual, so I assume that Vivus did not support this work. They must now have some agreement with Dr Christ. They would not pay him as a consultant, involve him in the Vivus gene therapy program with some agreement over rights their collaborative work? I guess they pay him a fee, give him money to support his research and have already some deal over rights. I don't know. As usual, the problem is that we don't know some crucial things. I await a reply from Dr Christ. DaiS